This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IDEXX Laboratories Inc (IDXX)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 1.60B 1.49B 1.38B 1.29B
Cost of Sales 641.23M 610.80M 566.34M 541.78M
Gross Operating Profit 960.66M 875.00M 810.71M 751.56M
Selling, General, and Administrative Expenses 482.46M 457.60M 401.35M 354.57M
Research & Development 99.68M 98.26M 88.00M 82.01M
Operating Income before D & A (EBITDA) 378.51M 319.14M 321.36M 314.97M
Depreciation & Amortization 70.39M 58.89M 54.60M 52.41M
Interest Income 2.47M 1.73M 1.89M 1.90M
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges -8.21M 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 302.38M 261.98M 268.65M 264.46M
Interest Expense 29.24M 15.43M 5.39M 3.85M
Pre-Tax Income 273.14M 246.56M 263.26M 260.62M
Income Taxes 81.01M 64.60M 75.47M 82.33M
Minority Interest 57.00K 45.00K -6.00K 20.00K
Net Income From Continuing Operations 192.13M 181.95M 187.79M 178.29M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 192.13M 181.95M 187.79M 178.29M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 192.08M 181.91M 187.80M 178.27M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
200.35M 181.95M 187.79M 178.29M
Preferred Dividends
Net Income Available To Common 192.13M 181.95M 187.79M 178.29M
Basic EPS from Continuing Ops. 2.07 1.82 1.77 1.62
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 2.07 1.82 1.77 1.62
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 2.07 1.82 1.77 1.62
Basic Normalized Net Income/Share 2.16 1.82 1.77 1.62
EPS fr Continuing Ops. 2.05 1.79 1.74 1.59
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 2.05 1.79 1.74 1.59
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 2.05 1.79 1.74 1.59
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
2.14 1.79 1.74 1.59
Dividends Paid per Share 0.00 0.00 0.00 0.00
IDXX News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

IDXX IDEXX Laboratories Inc

Chart of IDXX

Analysts Ratings for IDXX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 3 2 3 3
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
GET IDXX ANALYST REPORT

IDXX Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs